+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

Hypothyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypothyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 39 Pages
  • Global
From
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 100 Pages
  • Global
From
Acromegaly Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acromegaly Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 78 Pages
  • Global
From
Epidermal Growth Factor Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Epidermal Growth Factor Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 259 Pages
  • Global
From
Insulin Delivery Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Thumbnail Image

Insulin Delivery Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • July 2024
  • 157 Pages
  • Global
From
Africa Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Africa Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • February 2024
  • 100 Pages
  • Africa
From
Russia Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Russia Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • February 2024
  • 80 Pages
  • Russia
From
United Kingdom Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Kingdom Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • February 2024
  • 80 Pages
  • United Kingdom
From
Poland Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Poland Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • February 2024
  • 80 Pages
  • Poland
From
Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights - Product Thumbnail Image

Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights

  • Report
  • December 2025
  • Global
From
Medicaments Containing Hormones but not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Medicaments Containing Hormones but not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • December 2025
  • Global
From
Medicaments Containing Insulin but not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Medicaments Containing Insulin but not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • December 2025
  • Global
From
Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • December 2025
  • Global
From
China - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights - Product Thumbnail Image

China - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights

  • Report
  • December 2025
  • China
From
U.S. - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights - Product Thumbnail Image

U.S. - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights

  • Report
  • December 2025
  • United States
From
United Kingdom - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights - Product Thumbnail Image

United Kingdom - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights

  • Report
  • December 2025
  • United Kingdom
From
Northern America - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights - Product Thumbnail Image

Northern America - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights

  • Report
  • December 2025
  • North America
From
EU - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights - Product Thumbnail Image

EU - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights

  • Report
  • December 2025
  • Europe
From
Middle East - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights - Product Thumbnail Image

Middle East - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights

  • Report
  • December 2025
  • Middle East
From
Asia - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights - Product Thumbnail Image

Asia - Medicaments Containing insulin but not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and insights

  • Report
  • December 2025
  • Asia Pacific
From
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more